AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05991882 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Condition 6: Craving daily+Craving trigger
Description: Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction messages delivered once daily and craving reduction trigger messages that will be based on responses to signal-contingent EMA questions.
Study NCT05991882 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Condition 7: Craving daily+Craving trigger+PBS daily+PBS trigger
Description: Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction and PBS messages delivered once daily and non-repetitive craving reduction and PBS trigger messages that will be based on responses to signal-contingent EMA questions.
Study NCT05874076 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Physiotherapy
Study NCT05874076 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: Physiotherapy
Study NCT05494450 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ExufiberAG+
Description: confirm performance and safety of the Exufiber Ag+ dressing in medium to high exuding chronic wounds
Study NCT06253611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 240 mg IV; every 2 weeks
Study NCT06253611 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab
Description: Nivolumab 240 mg IV; every 2 weeks
Study NCT06253611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFOX regimen
Description: Oxaliplatin 85 mg/m², leucovorin 400 mg/m², bolus of 5-FU 400 mg/m², continuous 5-FU 2400/m² in 46 hours; every 2 weeks
Study NCT06253611 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFOX regimen
Description: Oxaliplatin 85 mg/m², leucovorin 400 mg/m², bolus of 5-FU 400 mg/m², continuous 5-FU 2400/m² in 46 hours; every 2 weeks
Study NCT06253611 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EXL01
Description: Orally 1 capsule/day, starting on day 1 of each FOLFOX/nivolumab treatment.
Study NCT05422599 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lemon balm
Description: 300mg Lemon balm and Maltoxdextrin capsules Other Name: Melissa Officinalis L.
Study NCT05422599 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 300mg Maltodextrin capsules
Study NCT06200077 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Modified Ridge-Splitting
Description: Unlike the conventional ridge-splitting where bone grafting is done in the same visit after ridge splitting, modified ridge splitting involves splitting the ridge only at the first visit, then bone grafting is done either alone afterwards in the second visit (Modified 3-Staged Ridge-Splitting Group) and dental implants will be placed in the third visit, or, as in the Modified 2-Staged Ridge-Splitting Group, bone grafting and dental implants placement will be done in the second visit.
Study NCT06200077 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified Ridge-Splitting
Description: Unlike the conventional ridge-splitting where bone grafting is done in the same visit after ridge splitting, modified ridge splitting involves splitting the ridge only at the first visit, then bone grafting is done either alone afterwards in the second visit (Modified 3-Staged Ridge-Splitting Group) and dental implants will be placed in the third visit, or, as in the Modified 2-Staged Ridge-Splitting Group, bone grafting and dental implants placement will be done in the second visit.
Study NCT06200077 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified Ridge-Splitting
Description: Unlike the conventional ridge-splitting where bone grafting is done in the same visit after ridge splitting, modified ridge splitting involves splitting the ridge only at the first visit, then bone grafting is done either alone afterwards in the second visit (Modified 3-Staged Ridge-Splitting Group) and dental implants will be placed in the third visit, or, as in the Modified 2-Staged Ridge-Splitting Group, bone grafting and dental implants placement will be done in the second visit.
Study NCT05070910 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapy
Description: The intervention performed in the practicum will not be able to be influenced by the study investigators and the intervention may be different for each child based on their needs
Study NCT05991882 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Condition 8: No daily or trigger craving or PBS
Description: Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will not receive any further intervention strategies.
Study NCT05909280 — intervention group
Intervention type: OTHER
Intervention: Pressure-volume loop measurements
Description: Pressure-volume loop measurements using a conductance catheter
Study NCT02562612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SM-88
Description: Daily SM-88 in multiple ascending doses over 6 months
Study NCT06115083 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor re-education using bio-feedback and home training
Description: Pelvic floor re-education using bio-feedback and home training
Study NCT05529030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Salience of Omicron variant
Description: The message mentions the Omicron variant, which can be a fear appeal or make salient the reason for the new booster
Study NCT05529030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-protection message
Description: The message makes a reference to protecting one's self
Study NCT05475327 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Physical Therapy
Description: Heating pad~A total of 3 sessions per week were given for 15 to 20 mins
Study NCT05475327 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Relaxation exercises
Description: The experimental group was given Progressive relaxation exercises along with Deep breathing exercises.~A total of 3 sessions per week were given for 15 to 20 mins.
Study NCT04982302 — intervention group
Intervention type: PROCEDURE
Intervention: Non-surgical periodontal treatment
Description: Subgingival instrumentation with ultrasonic devices and curettes of all periodontal pockets
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg
Description: One 600mg tablet taken orally once daily (QD) in the morning during weeks 1-26
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid 1200 mg (QD)
Description: Two 600mg tablets taken orally once daily (QD) in the morning during weeks 1-4
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid 1200 mg (TIW)
Description: Two 600mg tablets taken orally three times per week (TIW; Mon-Wed-Fri) in the morning during weeks 5-26
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bedaquiline 200 mg
Description: Two 100mg tablets taken orally once daily in the morning during weeks 1-8
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bedaquiline 100 mg
Description: One 100mg tablet taken orally once daily in the morning during weeks 9-26
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delamanid 300 mg
Description: Six 50mg tablets taken orally once daily in the morning during weeks 1-26
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofazimine 300 mg
Description: Three 100mg capsules taken orally once daily in the morning during weeks 1-2
Study NCT05007821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofazimine 100 mg
Description: One 100mg capsule taken orally once daily in the morning during weeks 3-26
Study NCT05946616 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation (tACS) combined with behavioral intervention
Description: Transcranial alternating current stimulation (tACS) combined with behavioral intervention (memory interference).
Study NCT05946616 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Inactive (sham) stimulation combined with behavioral intervention
Description: Inactive (sham) stimulation combined with behavioral intervention (memory interference)
Study NCT05529030 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Other-protection message
Description: The message makes a reference to protecting others (patients)
Study NCT05618886 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: The education about urinary incontinence, PFM and PFMT together with lifestyle behavior modifications such as using the knack, maintaining healthy weight, toilet habits, and reducing constipation and intra-abdominal pressure will be provided along with the PFMT instruction.
Study NCT05618886 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and PFMT
Description: Along with education twelve weekly face-to-face sessions of PFMT with exercises individually or in groups with the women's health physiotherapist will be offered. PFMT will be taught on the basis of observation, vaginal palpation and camtech manometry, and will be individualized initially to suit each participant's ability within a protocol encouraging 10 close-to-maximum contractions and 6-8-second hold with a 10-second rest between contractions. During the first two appointments, participant's will be instructed to perform two sessions with rest in between and thereafter three times 10 contractions if possible during each visit. The participant's will be encouraged to perform daily PFMT (10 contraction x 3 10times, 3 sets) at home and will be asked to record their PFMT in an exercise diary.
Study NCT05817682 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interprofessional education
Description: The study will be conducted among students of the Krakow Academy. The experimental group will consist of 35 students participating in the Interdisciplinary Circle of Medical Simulation from the following faculties: medicine, nursing and medical rescue.~Students will be divided into 7 interprofessional teams, in which they will take classes planned for small groups.
Study NCT06547411 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PC Ventilation mode
Description: Patients were randomly assigned to three groups using a random number table and the random remainder grouping method at a ratio of 1:1:1. Group I received pressure control ventilation (PC).
Study NCT06547411 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VC Ventilation mode
Description: Patients were randomly assigned to three groups using a random number table and the random remainder grouping method at a ratio of 1:1:1. Group II received volume control ventilation (VC).
Study NCT06547411 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRVC Ventilation mode
Description: Patients were randomly assigned to three groups using a random number table and the random remainder grouping method at a ratio of 1:1:1. Group III received pressure-regulated volume control ventilation (PRVC).
Study NCT06551779 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: inyección perineural con solución de dextrosa tamponada
Description: Application of perineural injection with buffered dextrose solution, adding 2.5 ml of 7.5% sodium bicarbonate to a 250 ml bottle of glucose solution at 5% concentration, applying 1cc of the solution at different points on the path of the facial nerve.
Study NCT04514484 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04514484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib S-malate
Description: Given PO
Study NCT04514484 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04514484 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04514484 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT06583473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive digital health application
Description: The study program will provide an integrated interactive digital health application (LINE app on smartphones, incorporating information about biodata recording, health education, questionnaires, and online Q\&A)
Study NCT04566289 — intervention group
Intervention type: DEVICE
Intervention: PiCSO
Description: Percutaneous coronary intervention
Study NCT04920799 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nitrate rich beetroot juice
Description: Participants will drink nitrate rich beetroot juice (2.4 floz ; Beet It Sport Nitrate 400 concentrated beetroot shot; James White Drink, ltd) twice daily for two weeks.
Study NCT04920799 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nitrate depleted beetroot juice
Description: Participants will drink nitrate depleted beetroot juice (2.4 floz ; Beet It placebo concentrated beetroot shot; James White Drink, ltd) twice daily for two weeks.
Study NCT05017909 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face to face education
Description: Face to face education techniques on the acquisition of the mothering Role
Study NCT05017909 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web based education
Description: web based education techniques on the acquisition of the mothering Role
Study NCT05017909 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: No education
Description: Control group will not be educated
Study NCT05830279 — intervention group
Intervention type: GENETIC
Intervention: Pharmacogenetic testing
Description: Genotyping for CYP2D6 and CYP2C19
Study NCT05830279 — intervention group
Intervention type: OTHER
Intervention: Drug-Drug interaction analysis
Description: Evaluating potential drug interactions with CYP2D6, CYP2C9 and CYP3A4 inhibitors and inducers using the Medical Letter.
Study NCT05771844 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Electrical Stimulation
Description: Oscillating electrical current
Study NCT04685408 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TEAM
Description: TEAM is informed by principles of social cognitive theory TEAM uses nurses and peer educator dyads (PEDs) composed of patients and their care partners to co-deliver an intervention intended to help reduce future stroke risk. Team begins with one 60-minute 1:1 orientation session, in which the nurse and PED meet with the patient and his/her care partner. This is followed by 6 hour-long group sessions with 6-8 patients and their care partners held approximately weekly. The first orientation session will be done approximately 1 week post baseline, followed by group sessions were done at 2, 4, 6, 8, 10 and 12 weeks post-baseline.
Study NCT04685408 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ETAU
Description: ETAU will consist of an orientation visit with a nurse who will provide patient-education materials on stroke risk adapted from the American Heart Association materials and cover common risk factors such as hypertension, obesity, high salt/high fat diet and diabetes. Patients will also receive basic written information in their language of preference and tailored to the reading level of most patients at the clinic. Patients will be offered the opportunity to bring a family member with them to this visit who may also ask questions and who can assist them with understanding written materials for those with limited literacy. The nurse in ETAU will then follow-up with participants with a series of 9 brief phone calls spaced out over the course of 6 months (approximately every 2 weeks during months 1 and 2, then approximately monthly thereafter). Content will reinforce materials provided in the orientation visit and the nurse will be available to answer questions that may arise.
Study NCT04836416 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Observational
Study NCT06446908 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth coaching for liver disease
Description: This study is an open-label, mono-centred, single-case experimental design with multiple base levels. The study will comprise 3 phases, alternating periods of observation (A) and 1 period of counselling (B) with an A1-B-A2 design.~PA will be assessed continuously using an accelerometer for 7 to 14 days per (A) phase. During phase (B), participants will receive the intervention, i.e. 6 x 45-minute, real-time, face-to-face, virtual sessions with a PA counsellor.
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Flavanol Cocoa Powder
Description: Measure the response 2 and 6 hours post low flavanol cocoa intake
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: High Flavanol Cocoa Powder
Description: Measure the response 2 and 6 hours post high flavanol cocoa intake
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Flavanol Cocoa Powder
Description: Measure the response 2 and 6 hours post high flavanol cocoa intake
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vine to Bar Chocolate - 2 servings
Description: Measure the response 2 and 6 hours post chocolate intake
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vine to Bar Chocolate - 2 servings
Description: Measure the response 2 and 6 hours post chocolate intake
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vine to Bar Chocolate - 1 serving
Description: Measure the response 2 and 6 hours post chocolate intake
Study NCT05545865 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vine to Bar Chocolate - 1 serving
Description: Measure the response 2 and 6 hours post chocolate intake
Study NCT05194618 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Valerian - lavender
Description: 1 tablet per day, half hour before bedtime, day 1 to day 28
Study NCT05194618 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 tablet per day, half hour before bedtime, day 1 to day 28
Study NCT05383768 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C
Description: Intervention 1: restoration with one-time preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C (Yang et al., 2020).~Intervention 2: Restoration with five time preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C (Yang et al., 2020).~Intervention 3: Restoration with ten time preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C (Yang et al., 2020).
Study NCT05383768 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C
Description: Intervention 1: restoration with one-time preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C (Yang et al., 2020).~Intervention 2: Restoration with five time preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C (Yang et al., 2020).~Intervention 3: Restoration with ten time preheated conventional bulk-fill resin composite, X-tra fill (VOCO, GERMANY) at 68◦C (Yang et al., 2020).
Study NCT04565301 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: adductor canal block
Study NCT04565301 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: neostigmine
Description: adductor canal block
Study NCT04565301 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: NaCl solutions
Description: adductor canal block
Study NCT05594914 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: AK104 plus TC regimen(paclitaxel liposome , carboplatin), once every 3 weeks (Q3W), induction treatment for 2 cycles; Subsequently, AK104 plus TC regimen is combined with radiotherapy for 2 cycles.
Study NCT06543069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab, Bevacizumab , Pemetrexed , Cisplatin
Description: Sintilimab: 200mg, bevacizumab: 7.5mg/kg, pemetrexed: 500mg/m2, cisplatin: 75mg /m2, Q3w. Tumor assessments will be performed every two cycles according to RECIST 1.1 criteria. After 6 cycles, maintenance therapy with sintilimab, bevacizumab, and pemetrexed will continue until disease progression or unacceptable toxicity occurs.
Study NCT05479955 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 5 minutes skin to skin contact
Description: Skin-to-skin contact is defined as placing a naked baby on the mother's bare stomach or breast for at least one hour immediately after birth. The women in this group received 5 minutes of skin-to-skin contact as a clinic routine.